Pharmacokinetics and Safety of Intrathecal Liposomal Cytarabine in Children Aged <3 Years

By Peyrl Andreas  

Clinical Pharmacokinetics, Vol. 48, Iss. 4, 2009-06 ,pp. : 265-271

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Metformin

By Graham Garry G.  

Clinical Pharmacokinetics, Vol. 50, Iss. 2, 2011-02 ,pp. : 81-98

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Propiverine in Children Aged between 5 and 10 Years with Symptoms of Overactive Bladder

By Siegmund Werner  

Clinical Pharmacokinetics, Vol. 49, Iss. 5, 2010-05 ,pp. : 335-342

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55–70 years

By Rembratt Asa   Graugaard-Jensen Charlotte   Senderovitz Thomas   Norgaard Jens   Djurhuus Jens  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 6, 2004-09 ,pp. : 397-402

Springer Publishing Company

Access to resources Recommend Favorite

Safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate, a novel inhaled corticosteroid, in children aged 5–11 years with persistent asthma: A randomized trial

By  

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 2, 2014-03 ,pp. : 144-150

John Wiley & Sons Inc

Access to resources Recommend Favorite